On the HCPLive Ulcerative Colitis condition center page, resources on the topics of medical news and expert insight into colitis can be found. Content includes articles, interviews, videos, podcasts, and breaking news on UC research, treatment, and drug development.
October 27th 2024
Post hoc analyses from the LIBERTY trials support infliximab as either a monotherapy or combination therapy for ulcerative colitis or Crohn's disease.
Q&A with Peter Higgins: Why Dialogue about Nutrition is Key for IBD Patients
Peter Higgins, MD, PhD, University of Michigan Health System, talked about how patients these days are often answering their own nutritional questions on the "Wild Wild West" of the Internet, so it's up to the experts to provide thorough answers to assuage their concerns.
Q&A with Peter Higgins: How to Implement a Nutrition Program for IBD Patients
At the 2015 Advances in Inflammatory Bowel Diseases (AIBD) meeting in Orlando, Florida, Peter Higgins, MD, PhD, the University of Michigan Health System shared his insight about the importance and value of careful nutritional guidance for IBD patients.
Are Probiotics Effective in the Remission of Ulcerative Colitis?
December 11th 2015It’s been suggested that probiotics can help prevent relapses in ulcerative colitis, but a new analysis presented in a poster session at the 2015 Advances in Inflammatory Bowel Diseases conference (AIBD 2015) in Orlando, Florida argues that that’s not the case.
IBD Patients Are Taking Steroids for Too Long
Measures in place to limit systemic steroid use for patients with inflammatory bowel disease are not as effective as they need to be. They should be replaced by a two-part model to examine drug utilization patterns that would separately consider factors associated with initiation and duration of therapy.
Medication Use Differs Between Young and Elderly Patients with IBD
December 11th 2015Hospitalization and mortality is more likely in elderly patients with inflammatory bowel disease (IBD) when compared to their younger counterparts. With 5-aminosalicylates (5-ASA) and corticosteroids becoming more popular in this age group, it’s not clear how they affect patients in the long run.
Q&A with Eva Szigethy: Prevent & Treat Opioid Dependence in Pediatric IBD Patients
Eva Szigethy, MD, PhD, University of Pittsburgh discussed at the 2015 Advances in Inflammatory Bowel Diseases (AIBD) how to continue the conversation and implement methods to treat the burgeoning concern of opioid dependence among pediatric IBD patients.
Fatigue Leads to Increased Pain Intensity in IBD
December 11th 2015Fatigue is two to three times more likely to appear in patients with inflammatory bowel disease (IBD) than in healthy controls. Researchers from Østfold University College in Norway found that the common symptom can lead to additional interferences.
Q&A with Russell Cohen: Healthcare Economics and Its Impact on IBD
Russell Cohen, MD, director of the Inflammatory Bowel Diseases Center at The University of Chicago Medicine continued to discuss the relevance of healthcare economics specific to IBD at the 2015 Advances in Inflammatory Bowel Diseases.
Q&A with Russell Cohen: Does the Westernization of Countries Lead to Westernized Diseases?
Russell Cohen, MD, director of the Inflammatory Bowel Diseases Center at The University of Chicago Medicine, discussed the progress made not only in the clinical care of IBD, but also in the basic science group and translational core at the 2015 Advances in Inflammatory Bowel Diseases meeting in Orlando, FL.
IBS Treatment Is More Effective and Less Costly in the Primary Care Setting
Treatment for irritable bowel syndrome (IBS) is significantly more expensive when treated in secondary care settings than it is when treated in primary care settings -- without a corresponding increase in treatment effectiveness.
Are IBD and Other Comorbidities More Prevalent in Patients with Autism?
Incidences of inflammatory bowel disease (IBD) have grown in patients also suffering from autism spectrum disorders (ASD), a neurocognitive disorder characterized by an impaired ability to communicate and interact.